Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 935
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 438
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 181
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 109
SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells
Alicia Villacampa, Enrique Alfaro, Cristina Morales, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Insulin resistance in COVID-19 and diabetes
Nalini Govender, Olive P. Khaliq, Jagidesa Moodley, et al.
Primary care diabetes (2021) Vol. 15, Iss. 4, pp. 629-634
Open Access | Times Cited: 103
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
Marek Ostaszewski, Anna Niarakis, Alexander Mazein, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 10
Open Access | Times Cited: 80
TNF‐α/IFN‐γ synergy amplifies senescence‐associated inflammation and SARS‐CoV‐2 receptor expression via hyper‐activated JAK/STAT1
Renuka Kandhaya‐Pillai, Xiaomeng Yang, Tamar Tchkonia, et al.
Aging Cell (2022) Vol. 21, Iss. 6
Open Access | Times Cited: 66
Post-COVID syndrome, inflammation, and diabetes
Ali A. Rizvi, Amita Kathuria, Wael Al Mahmeed, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 11, pp. 108336-108336
Open Access | Times Cited: 55
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 43
Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
Iis Inayati Rakhmat, Yudith Yunia Kusmala, Dewi Ratih Handayani, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 777-782
Open Access | Times Cited: 53
Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update
Nhung Thi Phuong Nong, Jue‐Liang Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9508-9508
Open Access | Times Cited: 45
Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 543-550
Open Access | Times Cited: 43
The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
Wenxing Yang, Xuehong Sun, Jun Zhang, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108977-108977
Open Access | Times Cited: 41
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 32
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies
Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 307-307
Open Access | Times Cited: 33
Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations
Soodeh Mahdian, Mahboobeh Zarrabi, Yunes Panahi, et al.
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100541-100541
Open Access | Times Cited: 31
Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
Hamid Mirjalili, Seyed Alireza Dastgheib, Seyed Hossein Shaker, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 905-917
Open Access | Times Cited: 31
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1029-1052
Open Access | Times Cited: 13
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients
Francesca Amati, Chiara Vancheri, Andrea Latini, et al.
Heliyon (2020) Vol. 6, Iss. 10, pp. e05143-e05143
Open Access | Times Cited: 28
A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19
Ran Abuhasira, Irit Ayalon‐Dangur, Neta Zaslavsky, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 24
Decreased Circulating Dipeptidyl Peptidase-4 Enzyme Activity Is Prognostic for Severe Outcomes in Covid-19 Inpatients
Ákos Nádasdi, György Sinkovits, Ilona Bobek, et al.
Biomarkers in Medicine (2022) Vol. 16, Iss. 5, pp. 317-330
Open Access | Times Cited: 17
Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms
Celestino Sardu, Raffaele Marfella, Francesco Prattichizzo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1564-1564
Open Access | Times Cited: 17
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review
Kamyar Asadipooya, Artin Asadipooya, Reuben Adatorwovor
Archives of Virology (2024) Vol. 169, Iss. 6
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top